Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Dec 6th 2019, Crypto Chartbook – Staying alert in pat

Staying alert in pat We advocate a contrarian approach based on a time frame confluence system. When this confluence is absent as of right now, we do not open new large size positions. Most of the times we are positioned already and take possibly some reloads. The followin...
Korbinian Koller | December 9, 2019 |

Breaking China’s stranglehold on the North American REE supply chain

Rare earths (REEs) are critical to producing permanent magnets used in consumer electronics and electric vehicles. Ucore Rare Metals ( TSXV:UCU ) ( OTCQX:UURAF ) is a company focused on separating rare earth elements and supplying the resultant rare earth oxides to the a...
Coreena Robertson | June 26, 2023 |

Buzz on the Bullboards: Big Names Return

If you’re looking to see the stocks that investors have been keeping an eye on over the past week, you’ve come to the right place. The Stockhouse Community regularly acts as a microcosm of investor sentiment at large. Great results lead to a lot...
Omri Wallach | August 21, 2019 |

Tariffs Are Having a Bigger Effect on U.S. Manufacturing Than Initially Thought

The U.S. manufacturing sector contracted for the fifth straight month in December, with the monthly reading from the Institute for Supply Management (ISM) hitting its weakest point in more than 10 years. The purchasing manager’s index (PMI) fell to 47.2,...
Frank Holmes | January 8, 2020 |

Gold to Correct as Stocks Rally

It has taken a few weeks to play out but our warning of a correction in precious metals (first on August 18) is coming to pass. Last week Gold, Silver and GDX all formed big bearish reversals at multi-year resistance levels. Yes, these resistance levels (Gold $1550, Silver...
Jordan Roy-Byrne, CMT | September 10, 2019 |

Buzz on the Bullboards: The Best of 2019

It was a year of ups, downs, and everything in between. It was also a year marked by global economic uncertainty and a shakeup of some of the hottest investment sectors. Yet as 2019 winds down, a clear picture emerges. Markets recovered and hit new records after falling st...
Omri Wallach | December 18, 2019 |

Gold junior transforms property into profitable mine

SILVER PEAK, Nevada –Most of us in natural resources are awestruck when we see an operating mine. It is a time-consuming piece of work: complex. Sometimes problematic and expensive – producing an ounce of gold. Scorpio Gold ’s ( TSX: V.SGN , Stock Forum ...
Andy Hoffman | October 28, 2012 |

Buzz on the Bullboards: Mining, tech and cannabis make waves

Canada’s main stock index started the week on a positive note after a rough performance last week, only to pivot downward throughout the following days, suffering declines across major sectors. The Bank of Canada’s reduction of its target ...
Jonathon Brown | July 25, 2024 |

Sarepta Shares Get a 35% Boost from FDA Approval of 2nd DMD Drug

Sarepta Therapeutics shares traded 35% higher after the firm reported that the FDA approved its second RNA exon-skipping treatment drug VYONDYS 53 injection for the treatment of Duchenne's Muscular Dystrophy in patients amenable to skipping Exon 53. Yesterday evening,...
Streetwise Reports | December 16, 2019 |

DSI Says Palladium Approaching a Sell, and DSI Is on Sale

The price of palladium has been on a tear lately. Like every other investor I would love it if every one of my investments went up day after day. But it never seems to happen for me. Actually, in real life, the more days something goes up and the faster it...
Streetwise Reports | December 19, 2019 |
1 2 3